{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:08:36Z","timestamp":1763417316950,"version":"3.45.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04764-x","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:02:24Z","timestamp":1763413344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Morphometric prediction of mesenchymal stromal cell-like immunosuppressive capacity of human hair follicle dermal sheath cup cells: an implication for regenerative medicine in hair loss diseases"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5282-7366","authenticated-orcid":false,"given":"Hyuma","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemasa","family":"Jinguji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-0896","authenticated-orcid":false,"given":"Yosuke","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-5717","authenticated-orcid":false,"given":"Manabu","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"4764_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.semcdb.2012.08.011","volume":"23","author":"R Sennett","year":"2012","unstructured":"Sennett R, Rendl M. Mesenchymal-epithelial interactions during hair follicle morphogenesis and cycling. Semin Cell Dev Biol. 2012;23:917\u201327.","journal-title":"Semin Cell Dev Biol"},{"key":"4764_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-0625.2009.00935.x","volume":"19","author":"M Ohyama","year":"2010","unstructured":"Ohyama M, Zheng Y, Paus R, Stenn KS. The mesenchymal component of hair follicle neogenesis: background, methods and molecular characterization. Exp Dermatol. 2010;19:89\u201399.","journal-title":"Exp Dermatol"},{"key":"4764_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaad.2020.02.033","volume":"83","author":"R Tsuboi","year":"2020","unstructured":"Tsuboi R, Niiyama S, Irisawa R, Harada K, Nakazawa Y, Kishimoto J. Autologous cell-based therapy for male and female pattern hair loss using dermal sheath cup cells: a randomized placebo-controlled double-blinded dose-finding clinical study. J Am Acad Dermatol. 2020;83:109\u201316.","journal-title":"J Am Acad Dermatol"},{"key":"4764_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1523-1747.2003.12568.x","volume":"121","author":"KJ McElwee","year":"2003","unstructured":"McElwee KJ, Kissling S, Wenzel E, Huth A, Hoffmann R. Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla. J Invest Dermatol. 2003;121:1267\u201375.","journal-title":"J Invest Dermatol"},{"key":"4764_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/46938","volume":"402","author":"AJ Reynolds","year":"1999","unstructured":"Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CA. Trans-gender induction of hair follicles. Nature. 1999;402:33\u20134.","journal-title":"Nature"},{"key":"4764_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbrc.2019.06.038","volume":"516","author":"Y Yoshida","year":"2019","unstructured":"Yoshida Y, Soma T, Matsuzaki T, Kishimoto J. Wnt activator CHIR99021-stimulated human dermal papilla spheroids contribute to hair follicle formation and production of reconstituted follicle-enriched human skin. Biochem Biophys Res Commun. 2019;516:599\u2013605.","journal-title":"Biochem Biophys Res Commun"},{"key":"4764_CR7","unstructured":"Harada K, Ohyama M, Niiyama S, Irisawa R, Mae K, Mori M, et al. Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single\u2010Arm, Multi\u2010Center, phase III equivalent clinical study. J Dermatol. 2023;1346\u20138138.16957."},{"key":"4764_CR8","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499\u2013506.","journal-title":"Blood"},{"key":"4764_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726\u201336.","journal-title":"Nat Rev Immunol"},{"key":"4764_CR10","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, G\u00f6therstr\u00f6m C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439\u201341.","journal-title":"Lancet"},{"key":"4764_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388:1281\u201390.","journal-title":"Lancet"},{"key":"4764_CR12","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.12998\/wjcc.v9.i15.3741","volume":"9","author":"H Ahn","year":"2021","unstructured":"Ahn H, Lee SY, Jung WJ, Lee K-H. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: three case reports and review of literature. WJCC. 2021;9:3741\u201351.","journal-title":"WJCC"},{"key":"4764_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","volume":"18","author":"J Galipeau","year":"2016","unstructured":"Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, et al. International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2016;18:151\u20139.","journal-title":"Cytotherapy"},{"key":"4764_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jcyt.2013.02.010","volume":"15","author":"M Krampera","year":"2013","unstructured":"Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L. MSC Committee of the International Society for Cellular Therapy (ISCT). Immunological characterization of multipotent mesenchymal stromal cells\u2014the International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy. 2013;15:1054\u201361.","journal-title":"Cytotherapy"},{"key":"4764_CR15","doi-asserted-by":"publisher","first-page":"E2598","DOI":"10.1073\/pnas.1617933114","volume":"114","author":"MW Klinker","year":"2017","unstructured":"Klinker MW, Marklein RA, Lo Surdo JL, Wei C-H, Bauer SR. Morphological features of IFN-\u03b3-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci USA. 2017;114:E2598\u2013607.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4764_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055082","volume":"8","author":"F Matsuoka","year":"2013","unstructured":"Matsuoka F, Takeuchi I, Agata H, Kagami H, Shiono H, Kiyota Y, et al. Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cells. PLoS ONE. 2013;8:e55082.","journal-title":"PLoS ONE"},{"key":"4764_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13287-017-0740-x","volume":"9","author":"S Oja","year":"2018","unstructured":"Oja S, Komulainen P, Penttil\u00e4 A, Nystedt J, Korhonen M. Automated image analysis detects aging in clinical-grade mesenchymal stromal cell cultures. Stem Cell Res Ther. 2018;9:6.","journal-title":"Stem Cell Res Ther"},{"key":"4764_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41232-021-00192-5","volume":"42","author":"Y Imai","year":"2022","unstructured":"Imai Y, Kanie K, Kato R. Morphological heterogeneity description enabled early and parallel non-invasive prediction of T-cell proliferation inhibitory potency and growth rate for facilitating donor selection of human mesenchymal stem cells. Inflamm Regener. 2022;42:8.","journal-title":"Inflamm Regener"},{"key":"4764_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/scd.2006.15.49","volume":"15","author":"MJ Hoogduijn","year":"2006","unstructured":"Hoogduijn MJ, Gorjup E, Genever PG. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev. 2006;15:49\u201360.","journal-title":"Stem Cells Dev"},{"key":"4764_CR20","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1007\/s12015-021-10288-7","volume":"18","author":"H Li","year":"2022","unstructured":"Li H, Ziemer M, Stojanovic I, Saksida T, Maksimovic-Ivanic D, Mijatovic S, et al. Mesenchymal stem cells from mouse hair follicles reduce hypertrophic scarring in a murine wound healing model. Stem Cell Rev and Rep. 2022;18:2028\u201344.","journal-title":"Stem Cell Rev and Rep"},{"key":"4764_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13619-020-00051-7","volume":"9","author":"AKA Zaki","year":"2020","unstructured":"Zaki AKA, Almundarij TI, Abo-Aziza FAM. Comparative characterization and osteogenic\/adipogenic differentiation of mesenchymal stem cells derived from male rat hair follicles and bone marrow. Cell Regen. 2020;9:13.","journal-title":"Cell Regen"},{"key":"4764_CR22","first-page":"1","volume":"2015","author":"X Wang","year":"2015","unstructured":"Wang X, Hao J, Leung G, Breitkopf T, Wang E, Kwong N, et al. Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression. J Immunol Res. 2015;2015:1\u201315.","journal-title":"J Immunol Res"},{"key":"4764_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"4764_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/biomedicines10020253","volume":"10","author":"B Hernaez-Estrada","year":"2022","unstructured":"Hernaez-Estrada B, Gonzalez-Pujana A, Cuevas A, Izeta A, Spiller KL, Igartua M, et al. Human hair follicle-derived mesenchymal stromal cells from the lower dermal sheath as a competitive alternative for immunomodulation. Biomedicines. 2022;10:253.","journal-title":"Biomedicines"},{"key":"4764_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/jid.2013.368","volume":"134","author":"X Wang","year":"2014","unstructured":"Wang X, Marr AK, Breitkopf T, Leung G, Hao J, Wang E, et al. Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege. J Invest Dermatol. 2014;134:736\u201345.","journal-title":"J Invest Dermatol"},{"key":"4764_CR26","first-page":"1404","volume":"10","author":"CM Magro","year":"2011","unstructured":"Magro CM, Rossi A, Poe J, Manhas-Bhutani S, Sadick N. The role of inflammation and immunity in the pathogenesis of androgenetic alopecia. J Drugs Dermatol JDD. 2011;10:1404\u201311.","journal-title":"J Drugs Dermatol JDD"},{"key":"4764_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1046\/j.1365-4362.2000.00612.x","volume":"39","author":"YF Mah\u00e9","year":"2000","unstructured":"Mah\u00e9 YF, Michelet J, Billoni N, Jarrousse F, BTS, Buan B, et al. Androgenetic alopecia and microinflammation. Int J Dermatol. 2000;39:576\u201384.","journal-title":"Int J Dermatol"},{"key":"4764_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1046\/j.1365-2133.2000.03464.x","volume":"142","author":"T Christoph","year":"2000","unstructured":"Christoph T, M\u00fcller-R\u00f6ver S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, et al. The human hair follicle immune system: cellular composition and immune privilege: the human hair follicle immune system. Br J Dermatol. 2000;142:862\u201373.","journal-title":"Br J Dermatol"},{"key":"4764_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1172\/JCI26043","volume":"116","author":"M Ohyama","year":"2005","unstructured":"Ohyama M. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2005;116:249\u201360.","journal-title":"J Clin Invest"},{"key":"4764_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.it.2004.09.014","volume":"26","author":"R Paus","year":"2005","unstructured":"Paus R, Nickoloff B, Ito T. A? hairy? privilege. Trends Immunol. 2005;26:32\u201340.","journal-title":"Trends Immunol"},{"key":"4764_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni1328","volume":"7","author":"JY Niederkorn","year":"2006","unstructured":"Niederkorn JY. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol. 2006;7:354\u20139.","journal-title":"Nat Immunol"},{"key":"4764_CR32","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M, G\u00f6bel U, D\u00e4ubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103:4619\u201321.","journal-title":"Blood"},{"key":"4764_CR33","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","volume":"111","author":"GM Spaggiari","year":"2008","unstructured":"Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008;111:1327\u201333.","journal-title":"Blood"},{"key":"4764_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/icb.2010.47","volume":"88","author":"S Tipnis","year":"2010","unstructured":"Tipnis S, Viswanathan C, Majumdar AS. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7\u2013H1 and IDO. Immunol Cell Biol. 2010;88:795\u2013806.","journal-title":"Immunol Cell Biol"},{"key":"4764_CR35","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1158\/0008-5472.CAN-08-2106","volume":"69","author":"F Qian","year":"2009","unstructured":"Qian F, Villella J, Wallace PK, Mhawech-Fauceglia P, Tario JD, Andrews C, et al. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase\u2013mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer Res. 2009;69:5498\u2013504.","journal-title":"Cancer Res"},{"key":"4764_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/stem.3185","volume":"38","author":"RI Azevedo","year":"2020","unstructured":"Azevedo RI, Minskaia E, Fernandes-Platzgummer A, Vieira AIS, da Silva CL, Cabral JMS, et al. Mesenchymal stromal cells induce regulatory T cells via epigenetic conversion of human conventional CD4 T cells in vitro. Stem Cells. 2020;38:1007\u201319.","journal-title":"Stem Cells"},{"key":"4764_CR37","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/stem.2580","volume":"35","author":"S Loisel","year":"2017","unstructured":"Loisel S, Dulong J, M\u00e9nard C, Renoud M-L, Meziere N, Isabelle B, et al. Brief report: proteasomal indoleamine 2,3-dioxygenase degradation reduces the immunosuppressive potential of clinical grade-mesenchymal stromal cells undergoing replicative senescence. Stem Cells. 2017;35:1431\u20136.","journal-title":"Stem Cells"},{"key":"4764_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.devcel.2014.10.022","volume":"31","author":"W Rahmani","year":"2014","unstructured":"Rahmani W, Abbasi S, Hagner A, Raharjo E, Kumar R, Hotta A, et al. Hair follicle dermal stem cells regenerate the dermal sheath, repopulate the dermal papilla, and modulate hair type. Dev Cell. 2014;31:543\u201358.","journal-title":"Dev Cell"},{"key":"4764_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.devcel.2020.03.019","volume":"53","author":"W Shin","year":"2020","unstructured":"Shin W, Rosin NL, Sparks H, Sinha S, Rahmani W, Sharma N, et al. Dysfunction of hair follicle mesenchymal progenitors contributes to age-associated hair loss. Dev Cell. 2020;53:185-198.e7.","journal-title":"Dev Cell"},{"key":"4764_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13:392\u2013402.","journal-title":"Cell Stem Cell"},{"key":"4764_CR41","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jcyt.2015.04.001","volume":"17","author":"D Ma","year":"2015","unstructured":"Ma D, Kua JEH, Lim WK, Lee ST, Chua AWC. In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing. Cytotherapy. 2015;17:1036\u201351.","journal-title":"Cytotherapy"},{"key":"4764_CR42","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.stemcr.2016.05.011","volume":"6","author":"B Sacchetti","year":"2016","unstructured":"Sacchetti B, Funari A, Remoli C, Giannicola G, Kogler G, Liedtke S, et al. No Identical \u201cMesenchymal Stem Cells\u201d at Different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels. Stem Cell Rep. 2016;6:897\u2013913.","journal-title":"Stem Cell Rep"},{"key":"4764_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.lfs.2015.09.019","volume":"141","author":"D Trivanovi\u0107","year":"2015","unstructured":"Trivanovi\u0107 D, Jaukovi\u0107 A, Popovi\u0107 B, Krsti\u0107 J, Mojsilovi\u0107 S, Oki\u0107-Djordjevi\u0107 I, et al. Mesenchymal stem cells of different origin: comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression. Life Sci. 2015;141:61\u201373.","journal-title":"Life Sci"},{"key":"4764_CR44","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1111\/j.1600-6143.2012.04224.x","volume":"12","author":"LV Riella","year":"2012","unstructured":"Riella LV, Paterson AM, Sharpe AH, Chandraker A. Role of the PD-1 pathway in the immune response. Am J Transplant. 2012;12:2575\u201387.","journal-title":"Am J Transplant"},{"key":"4764_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/0974-7753.122963","volume":"5","author":"S Sacchidanand","year":"2013","unstructured":"Sacchidanand S, Biligi D, Palo S, Nirmal B, Somiah S. Evaluation of perifollicular inflammation of donor area during hair transplantation in androgenetic alopecia and its comparison with controls. Int J Trichol. 2013;5:73.","journal-title":"Int J Trichol"},{"key":"4764_CR46","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1590\/abd1806-4841.20153370","volume":"90","author":"PM Ramos","year":"2015","unstructured":"Ramos PM, Miot HA. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90:529\u201343.","journal-title":"An Bras Dermatol"},{"key":"4764_CR47","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1365-2133.2010.09661.x","volume":"162","author":"P Cousen","year":"2010","unstructured":"Cousen P, Messenger A. Female pattern hair loss in complete androgen insensitivity syndrome: female pattern hair loss. Br J Dermatol. 2010;162:1135\u20137.","journal-title":"Br J Dermatol"},{"key":"4764_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/mt.2011.189","volume":"20","author":"M Fran\u00e7ois","year":"2012","unstructured":"Fran\u00e7ois M, Romieu-Mourez R, Li M, Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2012;20:187\u201395.","journal-title":"Mol Ther"},{"key":"4764_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nbt.3525","volume":"34","author":"YY Lipsitz","year":"2016","unstructured":"Lipsitz YY, Timmins NE, Zandstra PW. Quality cell therapy manufacturing by design. Nat Biotechnol. 2016;34:393\u2013400.","journal-title":"Nat Biotechnol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04764-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04764-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04764-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:03:32Z","timestamp":1763417012000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04764-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4764"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04764-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the isolation of DSCC from human scalp tissue was granted by the human research ethics committees at the Shiseido Global Innovation Center, under the project titled \"Evaluation of Hair Follicle Regeneration Ability of Cultured Cells Derived from Scalp Tissue,\" granted on 15 March 2023 (#18000030). All donors provided written informed consent prior to participation. The BM-MSC, AD-MSC, and PBMC, were purchased from Promocell and Precision for Medicine. Both companies have confirmed that ethical approval was obtained for the collection of human cells, and that donors provided informed consent. Promocell and Precision for Medicine outline their compliance with ethical and regulatory standards in their official documents (Promocell:\n                      \n                      , Precision for Medicine:\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M Ohyama has earned advisory fees from Taisho Pharmaceutical Co. and ROHTO Pharmaceutical Co. concerning this study topic, along with lecture and advisory fees for unrelated topics from Eli Lilly Co., Pfizer Inc., Sanofi KK., Kyowa Kirin Co., Maruho Co., Bristol-Myers Squibb Japan, and AbbVie GK. He has received research funding for this study topic from Shiseido Co, Ltd., and for unrelated topics from Maruho Co., Advantest Co., and Sun Pharma Japan Ltd. HT, HL, HJ, SK, YN, and M Ogo are employees of Shiseido Co, Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"644"}}